{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:41:10Z","timestamp":1759531270862},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1097\/fbp.0b013e3280ebb400","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T09:06:57Z","timestamp":1173344817000},"page":"155-160","source":"Crossref","is-referenced-by-count":15,"title":["Plasma levels of rotigotine and the reversal of motor deficits in MPTP-treated primates"],"prefix":"10.1097","volume":"18","author":[{"given":"Sarah","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter K.A.","family":"Scheller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Breidenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Stockwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210202","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/mds.10589","article-title":"Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys","volume":"18","author":"Belanger","year":"2003","journal-title":"Mov Disord"},{"key":"R2-6-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mds.870090204","article-title":"N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease","volume":"9","author":"Belluzzi","year":"1994","journal-title":"Mov Disord"},{"key":"R3-6-20210202","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.expneurol.2004.11.013","article-title":"Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates","volume":"192","author":"Bibbiani","year":"2005","journal-title":"Exp Neurol"},{"key":"R4-6-20210202","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00023210-200418110-00003","article-title":"The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study","volume":"18","author":"Bracco","year":"2004","journal-title":"CNS Drugs"},{"key":"R5-6-20210202","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/mds.870130503","article-title":"N-0923, a novel soluble dopamine D2 agonist in the treatment of parkinsonism","volume":"13","author":"Calabrese","year":"1998","journal-title":"Mov Disord"},{"key":"R6-6-20210202","first-page":"1387","article-title":"Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys","volume":"265","author":"Domino","year":"1993","journal-title":"J Pharm Exp Ther"},{"key":"R7-6-20210202","first-page":"A293","article-title":"Stable rotigotine plasma concentrations over 24\u2009h in patients with early-stage parkinsons disease after once-daily transdermal administration of rotigotine (Neupro\u00ae)","volume":"66","author":"Elshoff","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00019052-200312001-00002","article-title":"Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease","volume":"16","author":"Jenner","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"R9-6-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(01)00139-5","article-title":"Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs","volume":"90","author":"Joyce","year":"2001","journal-title":"Pharmacol Ther"},{"key":"R10-6-20210202","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2999(89)90348-8","article-title":"Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437","volume":"166","author":"Loschmann","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"R11-6-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02245479","article-title":"Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets","volume":"109","author":"Loschmann","year":"1992","journal-title":"Psychopharmacology (Berlin)"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R13-6-20210202","first-page":"S167","article-title":"Preventing levodopa-induced dyskinesias","volume":"47","author":"Olanow","year":"2000","journal-title":"Ann Neurol"},{"key":"R14-6-20210202","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1523\/JNEUROSCI.12-10-03729.1992","article-title":"D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease","volume":"12","author":"Paul","year":"1992","journal-title":"J Neurosci"},{"key":"R15-6-20210202","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1212\/WNL.65.2_suppl_1.S11","article-title":"Clinical studies with transdermal rotigotine in early Parkinson's disease","volume":"65","author":"Poewe","year":"2005","journal-title":"Neurology"},{"key":"R16-6-20210202","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2165\/00023210-200519110-00006","article-title":"Rotigotine: In Parkinson's Disease","volume":"19","author":"Reynolds","year":"2005","journal-title":"CNS Drugs"},{"key":"R17-6-20210202","first-page":"103","article-title":"Evidence for continuous dopamine receptor stimulation by rotigotine in freely moving rats using a continuous delivery system","volume":"11","author":"Scheller","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"R19-6-20210202","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mds.870110203","article-title":"An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets","volume":"11","author":"Smith","year":"1996","journal-title":"Mov Disord"},{"key":"R20-6-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002826-200005000-00002","article-title":"Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset","volume":"23","author":"Smith","year":"2000","journal-title":"Clin Neuropharmacol"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008877-200703000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:39:13Z","timestamp":1618364353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-200703000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0b013e3280ebb400","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}